Pesticide that increases Parkinson’s risk by 150% reapproved in the US

News

Author: Simge Eva DoganPublished: 5 November 2020

Prep: Cook: Serves:

Agriculture worker. Young farmer spraying pesticides

The US Environmental Protection Agency (EPA) has allowed the continued use of paraquat, a pesticide that increases the risk of Parkinson’s disease by 150%.

The pesticide – which has already been banned in 32 countries – was reapproved by the EPA in October as part of a review of the safety of all herbicides and pesticides in the US, a process which takes place every 15 years.

Many studies have shown that as well as increased risk of Parkinson’s disease, exposure to the pesticide is associated with other health issues and risk of death. Exposure to paraquat endangers both the farmers who use the pesticide, as well as the families who can be exposed to it through the air or transfers onto clothing or other materials.

In response to the reapproval, the Michael J Fox Foundation is calling on the Parkinson’s community to ask senators and representatives to support a bill banning paraquat from use in the country.

Find out more about the reapproval of the pesticide paraquat in the US.

Scientists at MIT uncover new clues about Parkinson’s disease

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Cure3: making art for Parkinson’s research

Hear from the artists and designers raising money for Parkinson’s

Raise your glass to ‘Parkies’ – the new beer that’s raising funds for nurses

Ex-Pink Floyd tour manager launches own ‘Parkies’ beer

Telemedicine: how Sweden is reducing waiting times for Parkinson’s treatment

Video calling tech is speeding up access to advanced treatment

Study suggests why neurons die in Parkinson’s disease

Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Pesticide that increases Parkinson’s risk by 150% reapproved in the US

News

Author: Simge Eva DoganPublished: 5 November 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Cure3: making art for Parkinson’s research

Europe

Raise your glass to ‘Parkies’ – the new beer that’s raising funds for nurses

In my country

Telemedicine: how Sweden is reducing waiting times for Parkinson’s treatment

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Pesticide that increases Parkinson’s risk by 150% reapproved in the US

News

Author: Simge Eva DoganPublished: 5 November 2020

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Cure3: making art for Parkinson’s research

Europe

Raise your glass to ‘Parkies’ – the new beer that’s raising funds for nurses

In my country

Telemedicine: how Sweden is reducing waiting times for Parkinson’s treatment

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Sign in